Cell Free DNA (cfDNA) Testing Market: Future Demand and Top Key Players Analysis | 2029

 Drawing from trusted sources and expert analysis, this report helps businesses navigate the complex landscape of the cell free dna (cfdna) testing industry.

 



 How Much Is The Cell Free DNA (cfDNA) Testing Market Worth?
 The cell free dna (cfdna) testing market size has grown exponentially in recent years. It will grow from $8.74 billion in 2024 to $10.84 billion in 2025 at a compound annual growth rate (CAGR) of 24.0%. The growth in the historic period can be attributed to a rise in the adoption of cfDNA testing in prenatal care, increasing use of cfDNA analysis, growing interest in cfDNA research across various medical fields, and rise in gaining approvals from regulatory bodies.
 
 The cell free dna (cfdna) testing market size is expected to see exponential growth in the next few years. It will grow to $24.34 billion in 2029 at a compound annual growth rate (CAGR) of 22.4%. The growth in the forecast period can be attributed to a shift towards personalized medicine, enhancements in healthcare infrastructure, aging population and increasing incidence of cancer, increasing adoption of precision medicine, increasing awareness and acceptance of liquid biopsy techniques, and increasing investment and funding in cfDNA research. Major trends in the forecast period include adoption of liquid biopsy technologies, advancements in Next-Generation Sequencing (NGS) technology, integration of AI and machine learning in cfDNA testing, development of point-of-care cfDNA tests, and implementation of cloud-based platforms for data storage and analysis.
 
 Get your free sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=15757&type=smp
 
 What Are The Current Leading Growth Drivers For Cell Free DNA (cfDNA) Testing Market?
 The rising prevalence of cancer is expected to propel the growth of the cell-free DNA (cfDNA) testing market going forward. Cancer is a complex group of diseases characterized by the uncontrolled growth and spread of abnormal cells in the body. These cells can invade and destroy normal tissue and, if not controlled, can significantly harm the body. The prevalence of cancer is due to aging populations, shifts in lifestyle, environmental influences, and advancements in detection and diagnostic techniques. cfDNA testing detects genetic mutations associated with cancer at an early stage, often before symptoms appear. This allows for early intervention, improving patient outcomes and survival rates by identifying cancer in its initial stages. For instance, in February 2024, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, there are expected to be over 35 million new cases of cancer in 2050, a 77% increase over the projected 20 million cases in 2022. Therefore, the rising prevalence of cancer is driving the growth of the cell-free DNA (cfDNA) testing market.
 
 Which Segment Accounted For The Largest Cell Free DNA (cfDNA) Testing Market Share?
 The cell free dna (cfdna) testingmarket covered in this report is segmented — 
 
 1) By Product: Donor-Derived Cell-Free DNA; Circulating Cell-Free Tumor DNA; Cell-Free Fetal DNA
 2) By Platforms: Next Generation Sequencing (NGS); rPCR And Multiplexed PCR; qPCR And dPCR; Other platforms
 3) By Application: Oncology; Non-Invasive Prenatal Test (NIPT); Gynecology; Transplantation; Other Applications
 
 Subsegments:
 1) By Donor-Derived Cell-Free DNA: Organ Transplant Monitoring; Graft Rejection Detection
 2) By Circulating Cell-Free Tumor DNA: Cancer Detection; Minimal Residual Disease Monitoring; Liquid Biopsy
 3) By Cell-Free Fetal DNA: Non-Invasive Prenatal Testing (NIPT); Fetal Genetic Disorder Screening
 
 Cell Free DNA (cfDNA) Testing Market Emerging Trends And Opportunities
 Major companies operating in the cell-free DNA (cfDNA) testing market focus on developing innovative technologies, such as liquid biopsy tests that offer greater sensitivity, specificity, and efficiency in detecting cancer-related mutations and genetic alterations. Liquid biopsy tests refer to diagnostic procedures that allow oncologists to evaluate circulating cell-free DNA released by tumor cells, facilitating personalized, targeted therapy plans. For instance, in May 2023, Laboratory Corporation of America Holdings (Labcorp), a US-based life sciences company, launched Labcorp Plasma Focus, a new liquid biopsy test designed for patients with advanced or metastatic solid tumors. This test evaluates circulating cell-free DNA (cfDNA) released by tumor cells from a standard blood draw, making it minimally invasive and providing fast results. It enhances access to precision oncology by identifying clinically actionable biomarkers across several common cancers, such as non-small cell lung, colorectal, breast, esophageal, gastroesophageal junction, gastric cancers, and melanoma.
 
 Which Are The Top Companies To Hold The Market Share In Cell Free DNA (cfDNA) Testing Market?
 Major companies operating in the cell free DNA (cfDNA) testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., Qiagen N.V., Exact Sciences Corporation, Bio-Techne Corporation, Natera Inc., Myriad Genetics Inc., NeoGenomics Laboratories Inc., Invitae Corporation, Foundation Medicine Inc., Guardant Health Inc., Integrated DNA Technologies Inc., Caris Life Sciences Inc., Twist Bioscience Corporation, Adaptive Biotechnologies Corporation, Biodesix Inc., Biocept Inc., Personal Genome Diagnostics Inc., Agena Bioscience Inc., Menarini Silicon Biosystems Inc., Circulogene Theranostics LLC
 
 View the full cell free dna (cfdna) testing market report here:
 https://www.thebusinessresearchcompany.com/report/cell-free-dna-cfdna-testing-global-market-report
 
 Which Region Is Projected To Account For The Largest Share Of The Cell Free DNA (cfDNA) Testing Market?
 North America was the largest region in the cell-free DNA (cfDNA) testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell free DNA (cfDNA) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
 
 Contact Us:
 
 The Business Research Company 
 
 https://thebusinessresearchcompany.com/ 
 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 
 Email: info@tbrc.info 
 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Global Next-Generation Advanced Batteries Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    How Is the Next-Generation Advanced Batteries Market Expected to Expand in Terms of Size and Growth?  The next-generation advanced batteries market size has grown rapidly in recent years. It will grow from $14.21 billion in 2025 to $15.93 billion in 2026 at a compound annual growth rate (CAGR) of 11.9%. The growth in the historic period can be attributed to increasing adoption of electric vehicles, integration with renewable energy systems, the need for cost-effective alternatives to lithium-ion batteries, growing demand for energy storage solutions, government in...
Read more

Intense Pulsed Light (IPL) Facial Rejuvenation Device Industry Projected to Experience Accelerated Growth by 2029

Image
 Get 30% Off All Market Studies With Code ONLINE30 — Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends    What Is the Intense Pulsed Light (IPL) Facial Rejuvenation Device Market Growth Potential Across Different Regions?  The intense pulsed light (IPL) facial rejuvenation device market size has grown rapidly in recent years. It will grow from $1.05 billion in 2024 to $1.18 billion in 2025 at a compound annual growth rate (CAGR) of 12.3%. The growth in the historic period can be attributed to growing influence of social media beauty standards, increasing preference for youthful appearance, rising penetration of aesthetic clinics, rise in technological adoption in dermatology practices, increasing awareness of early anti-aging treatments.    The intense pulsed light (IPL) facial rejuvenation device market size is expected to see rapid growth in the next few years. It will grow to $1.85 billion in 2029 at a compound annual growth rate ...
Read more

Global Aggregate Stockpile Drones Market Outlook 2026-2030: Regional Growth and Sizing Insights

 The Business Research Company’s 2026 market reports introduce new features such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, all designed to enhance the depth, usability, and strategic value of the insights provided.    What Is the Forecasted Market Size of the Aggregate Stockpile Drones Market by 2030?  The aggregate stockpile drones market size has grown rapidly in recent years. It will grow from $1.04 billion in 2025 to $1.20 billion in 2026 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to growing need for accurate stockpile measurement, increasing adoption of drones in mining operations, rising focus on worker safety during surveying, expansion of quarry and aggregates production activities, growing shift from manual to ...
Read more